Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

Researchers found that combining cardiovascular disease drug classes, particularly antihypertensives, can reduce risk of dementia.

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

This University of Waterloo study shows how antipsychotic medications significantly worsened behavior in nursing home ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...